BSE Live
Jan 21, 16:01Prev. Close
3974.90
Open Price
3959.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 21, 15:47Prev. Close
3976.80
Open Price
3960.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
3981.80 (98)
| Key Financial Ratios of Torrent Pharmaceuticals (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 24.51 | 22.07 | 18.38 | 13.35 | 7.78 | |
| Diluted EPS (Rs.) | 24.51 | 22.07 | 18.38 | 13.35 | 7.78 | |
| Cash EPS (Rs.) | 30.94 | 26.49 | 22.25 | 16.92 | 10.58 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 104.10 | 86.59 | 69.16 | 54.88 | 45.21 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 104.10 | 86.59 | 69.16 | 54.88 | 45.21 | |
| Dividend / Share(Rs.) | 6.00 | 4.00 | 3.50 | 3.00 | 2.50 | |
| Revenue from Operations/Share (Rs.) | 169.82 | 139.98 | 117.73 | 104.75 | 82.18 | |
| PBDIT/Share (Rs.) | 51.30 | 32.57 | 25.93 | 20.64 | 14.59 | |
| PBIT/Share (Rs.) | 44.87 | 28.15 | 22.06 | 17.07 | 11.79 | |
| PBT/Share (Rs.) | 41.46 | 23.63 | 19.60 | 14.67 | 10.75 | |
| Net Profit/Share (Rs.) | 24.51 | 22.07 | 18.38 | 13.35 | 7.78 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 30.20 | 23.26 | 22.02 | 19.70 | 17.75 | |
| PBIT Margin (%) | 26.42 | 20.10 | 18.74 | 16.29 | 14.34 | |
| PBT Margin (%) | 24.41 | 16.87 | 16.64 | 14.00 | 13.08 | |
| Net Profit Margin (%) | 14.43 | 15.76 | 15.61 | 12.74 | 9.46 | |
| Return on Networth / Equity (%) | 23.54 | 25.48 | 26.57 | 24.32 | 17.20 | |
| Return on Capital Employed (%) | 15.32 | 15.32 | 16.12 | 14.21 | 9.62 | |
| Return on Assets (%) | 11.14 | 11.48 | 12.51 | 11.64 | 7.78 | |
| Total Debt/Equity (X) | 0.59 | 0.66 | 0.58 | 0.60 | 0.64 | |
| Asset Turnover Ratio (%) | 77.21 | 72.86 | 80.17 | 91.40 | 82.28 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.94 | 2.06 | 1.98 | 2.43 | 2.38 | |
| Quick Ratio (X) | 1.49 | 1.59 | 1.39 | 1.37 | 1.37 | |
| Inventory Turnover Ratio (X) | 6.31 | 6.17 | 5.98 | 4.77 | 4.26 | |
| Dividend Payout Ratio (NP) (%) | 24.48 | 18.12 | 19.04 | 22.47 | 32.13 | |
| Dividend Payout Ratio (CP) (%) | 19.39 | 15.10 | 15.73 | 17.72 | 23.63 | |
| Earnings Retention Ratio (%) | 75.52 | 81.88 | 80.96 | 77.53 | 67.87 | |
| Cash Earnings Retention Ratio (%) | 80.61 | 84.90 | 84.27 | 82.28 | 76.37 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 4,788.58 | 1,433.06 | 1,440.44 | 1,937.40 | 2,024.42 | |
| EV/Net Operating Revenue (X) | 3.33 | 1.21 | 1.45 | 2.19 | 2.91 | |
| EV/EBITDA (X) | 11.03 | 5.20 | 6.56 | 11.09 | 16.40 | |
| MarketCap/Net Operating Revenue (X) | 3.21 | 0.96 | 1.20 | 1.88 | 2.65 | |
| Retention Ratios (%) | 75.51 | 81.87 | 80.95 | 77.52 | 67.86 | |
| Price/BV (X) | 5.24 | 1.55 | 2.04 | 3.59 | 4.81 | |
| Price/Net Operating Revenue | 3.21 | 0.96 | 1.20 | 1.88 | 2.65 | |
| Earnings Yield | 0.04 | 0.16 | 0.13 | 0.07 | 0.04 |
09.01.2026
05.12.2025
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
12.11.2025
Torrent Pharma Standalone September 2025 Net Sales at Rs 2,762.00 crore, up 13.48% Y-o-Y
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
12.11.2025
Torrent Pharma Standalone September 2025 Net Sales at Rs 2,762.00 crore, up 13.48% Y-o-Y
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Standalone June 2025 Net Sales at Rs 2,616.00 crore, up 7.3% Y-o-Y
12.07.2023
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
17.01.2023
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang
13.07.2022
Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct
08.07.2022
Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher
24.07.2019
Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show
25.08.2018
Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz
22.01.2014
14.01.2012